☰

Eugene P. Frenkel - Publications

Affiliations: 
University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States 
Tree Info Similar researchers PubMed Report error

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Baird R, Arkenau H, Deva S, Cresti N, Garcia-Corbacho J, Hogarth L, Frenkel E, Kawaguchi K, Arimura A, Donaldson K, Posner J, Sarker D, Jodrell D, Plummer R, Spicer J, et al. Abstract P4-14-26: Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including HER2-positive breast cancer patients with brain metastases Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P4-14-26  0.345
2015 Huang YY, Chen P, Wu CH, Hoshino K, Sokolov K, Lane N, Liu H, Huebschman M, Frenkel E, Zhang JX. Screening and Molecular Analysis of Single Circulating Tumor Cells Using Micromagnet Array. Scientific Reports. 5: 16047. PMID 26538094 DOI: 10.1038/Srep16047  0.325
2015 Tian H, Lu JY, Shao C, Huffman KE, Carstens RM, Larsen JE, Girard L, Liu H, Rodriguez-Canales J, Frenkel EP, Wistuba II, Minna JD, Hofmann SL. Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5. Molecular Cancer Research : McR. 13: 784-94. PMID 25573953 DOI: 10.1158/1541-7786.Mcr-14-0608  0.306
2014 Agrawal V, Woo JH, Mauldin JP, Stone EM, Meininger CJ, Jo C, Kleypas K, Frenkel EP, Frankel AE. In-vivo evaluation of human recombinant Co-arginase against A375 melanoma xenografts. Melanoma Research. 24: 556-67. PMID 25304236 DOI: 10.1097/Cmr.0000000000000119  0.312
2014 Joseph RW, Kapur P, Serie DJ, Eckel-Passow JE, Parasramka M, Ho T, Cheville JC, Frenkel E, Rakheja D, Brugarolas J, Parker A. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma. Cancer. 120: 1059-67. PMID 24382589 DOI: 10.1002/Cncr.28521  0.326
2013 Wu CH, Huang YY, Chen P, Hoshino K, Liu H, Frenkel EP, Zhang JX, Sokolov KV. Versatile immunomagnetic nanocarrier platform for capturing cancer cells. Acs Nano. 7: 8816-23. PMID 24016305 DOI: 10.1021/Nn403281E  0.344
2012 Uhr JW, Huebschman ML, Frenkel EP, Lane NL, Ashfaq R, Liu H, Rana DR, Cheng L, Lin AT, Hughes GA, Zhang XJ, Garner HR. Molecular profiling of individual tumor cells by hyperspectral microscopic imaging. Translational Research : the Journal of Laboratory and Clinical Medicine. 159: 366-75. PMID 22500509 DOI: 10.1016/J.Trsl.2011.08.003  0.318
2012 Radaideh SM, Frenkel EP, Dowell JE, Sarode R, Shen YM. Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA. Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 18: 215-7. PMID 22067544 DOI: 10.1177/1076029611423389  0.302
2012 Liu X, Zhang W, Girard L, Gao B, Larsen J, Wistuba II, Frenkel E, Toombs J, Brekken R, Minna J, Gazdar A. Abstract LB-85: Ectopic expression of eukaryotic translation elongation factor eEF1A2 is a hallmark for human lung cancer and is associated with poor prognosis Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-85  0.311
2011 Hoshino K, Huang YY, Lane N, Huebschman M, Uhr JW, Frenkel EP, Zhang X. Microchip-based immunomagnetic detection of circulating tumor cells. Lab On a Chip. 11: 3449-57. PMID 21863182 DOI: 10.1039/C1Lc20270G  0.317
2011 Thompson EM, Frenkel EP, Neuwelt EA. The paradoxical effect of bevacizumab in the therapy of malignant gliomas. Neurology. 76: 87-93. PMID 21205697 DOI: 10.1212/Wnl.0B013E318204A3Af  0.31
2011 Raj GV, Karavadia S, Schlomer B, Arriaga Y, Lotan Y, Sagalowsky A, Frenkel E. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. Cancer. 117: 276-82. PMID 20830767 DOI: 10.1002/Cncr.25429  0.319
2010 Radaideh SM, Frenkel EP, Sarode R, Shen Y. Incidence of Isolated Heparin-Induced Thrombocytopenia and the Risk of Developing Subsequent Thrombosis Using the New IgG Specific Anti-PF4/Heparin ELISA Blood. 116: 1448-1448. DOI: 10.1182/Blood.V116.21.1448.1448  0.307
2008 Shivapurkar N, Stastny V, Okumura N, Girard L, Xie Y, Prinsen C, Thunnissen FB, Wistuba II, Czerniak B, Frenkel E, Roth JA, Liloglou T, Xinarianos G, Field JK, Minna JD, et al. Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene. Cancer Research. 68: 7448-56. PMID 18794132 DOI: 10.1158/0008-5472.Can-08-0565  0.321
2008 Shivapurkar N, Stastny V, Xie Y, Prinsen C, Frenkel E, Czerniak B, Thunnissen FB, Minna JD, Gazdar AF. Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 995-1000. PMID 18398044 DOI: 10.1158/1055-9965.Epi-07-2808  0.318
2008 Fan J, Stanfield J, Guo Y, Karam JA, Frenkel E, Sun X, Hsieh JT. Effect of trans-2,3-dimethoxycinnamoyl azide on enhancing antitumor activity of romidepsin on human bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1200-7. PMID 18281555 DOI: 10.1158/1078-0432.Ccr-07-1656  0.316
2008 Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urologic Oncology. 26: 57-64. PMID 18190833 DOI: 10.1016/J.Urolonc.2007.03.015  0.304
2007 Zhang Z, Stanfield J, Frenkel E, Kabbani W, Hsieh JT. Enhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel. Urology. 70: 396-401. PMID 17826527 DOI: 10.1016/J.Urology.2007.03.052  0.318
2007 Karam JA, Fan J, Stanfield J, Richer E, Benaim EA, Frenkel E, Antich P, Sagalowsky AI, Mason RP, Hsieh JT. The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. International Journal of Cancer. Journal International Du Cancer. 120: 1795-802. PMID 17230511 DOI: 10.1002/Ijc.22405  0.331
2006 Meng S, Tripathy D, Shete S, Ashfaq R, Saboorian H, Haley B, Frenkel E, Euhus D, Leitch M, Osborne C, Clifford E, Perkins S, Beitsch P, Khan A, Morrison L, et al. uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues. Proceedings of the National Academy of Sciences of the United States of America. 103: 17361-5. PMID 17079488 DOI: 10.1073/Pnas.0608113103  0.34
2006 Pong RC, Roark R, Ou JY, Fan J, Stanfield J, Frenkel E, Sagalowsky A, Hsieh JT. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application. Cancer Research. 66: 8822-8. PMID 16951199 DOI: 10.1158/0008-5472.Can-05-4672  0.317
2005 Dyszkiewicz-Korpanty AM, Sarode R, Thorpe PE, Frenkel EP. An Anti-Phosphatidylserine (PS) Antibody, Tarvacin™ That Targets Tumor Blood Vessels Does Not Affect Platelet Function In Vitro. Blood. 106: 3950-3950. DOI: 10.1182/Blood.V106.11.3950.3950  0.308
2004 Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, et al. Circulating tumor cells in patients with breast cancer dormancy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8152-62. PMID 15623589 DOI: 10.1158/1078-0432.Ccr-04-1110  0.329
2004 Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, et al. HER-2 gene amplification can be acquired as breast cancer progresses. Proceedings of the National Academy of Sciences of the United States of America. 101: 9393-8. PMID 15194824 DOI: 10.1073/Pnas.0402993101  0.334
2003 Becerra CR, Frenkel EP, Ashfaq R, Gaynor RB. Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study. International Journal of Cancer. Journal International Du Cancer. 105: 868-72. PMID 12767075 DOI: 10.1002/Ijc.11164  0.341
2002 Li Y, Okegawa T, Lombardi DP, Frenkel EP, Hsieh JT. Enhanced transgene expression in androgen independent prostate cancer gene therapy by taxane chemotherapeutic agents. The Journal of Urology. 167: 339-46. PMID 11743353 DOI: 10.1016/S0022-5347(05)65465-1  0.309
1996 Bick RL, Strauss JF, Frenkel EP. Thrombosis and hemorrhage in oncology patients. Hematology-Oncology Clinics of North America. 10: 875-908. PMID 8811307 DOI: 10.1016/S0889-8588(05)70374-9  0.335
1994 Sharma R, Singhal SS, Srivastava SK, Bajpai KK, Frenkel EP, Awasthi S. Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines. Cancer Letters. 75: 111-9. PMID 8293421 DOI: 10.1016/0304-3835(93)90195-F  0.524
1994 Awasthi S, Singhal SS, Srivastava SK, Zimniak P, Bajpai KK, Saxena M, Sharma R, Ziller SA, Frenkel EP, Singh SV. Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. The Journal of Clinical Investigation. 93: 958-65. PMID 7907606 DOI: 10.1172/Jci117102  0.492
1992 Awasthi S, Sharma R, Awasthi YC, Belli JA, Frenkel EP. The relationship of doxorubicin binding to membrane lipids with drug resistance Cancer Letters. 63: 109-116. PMID 1562987 DOI: 10.1016/0304-3835(92)90060-9  0.49
1992 Wilson WT, Frenkel E, Vuitch F, Sagalowsky AI. Testicular tumors in men with human immunodeficiency virus. The Journal of Urology. 147: 1038-1040. PMID 1552581 DOI: 10.1016/S0022-5347(17)37458-X  0.301
1984 Neuwelt EA, Hill SA, Frenkel EP. Osmotic blood-brain barrier modification and combination chemotherapy: Concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening Neurosurgery. 15: 362-366. PMID 6090973 DOI: 10.1227/00006123-198409000-00011  0.305
1983 Neuwelt EA, Balaban E, Diehl J, Hill S, Frenkel E. Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery. 12: 662-71. PMID 6410302 DOI: 10.1227/00006123-198306000-00013  0.314
1980 Neuwelt EA, Frenkel EP, Diehl J, Vu LH, Rapoport S, Hill S. Reversible osmotic blood-barrier disruption in humans: Implications for the chemotherapy of malignant brain tumors Neurosurgery. 7: 44-52. PMID 6251399 DOI: 10.1227/00006123-198007000-00007  0.314
1980 Ligler F, Smith R, Kettman J, Hernandez J, Himes J, Vitetta E, Uhr J, Frenkel E. Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess" Blood. 55: 792-801. DOI: 10.1182/Blood.V55.5.792.Bloodjournal555792  0.316
Show low-probability matches.